Olema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer Symposium

NEXT STORY
FINN Partners Expands its Omni-Channel Communications Capabilities with Addition of Pharmacy Podcast Network
PREV STORY
Affimed Announces 100% Objective Response Rate at Highest Dose in Phase 1-2 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13 for CD30-positive Lymphomas
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CapsoVision Announces U.S. Distribution Partnership With PENTAX Medical

The diagnostic and therapeutic endoscopy company will now sell CapsoVision capsule endoscopy solutions CapsoCam ...

author_avatar
NASDAQ Market News

Aclaris Therapeutics Reports Third Quarter 2015 Financial Results

MALVERN, Pa., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage ...

author_avatar
NASDAQ Market News

Global Vaccine Market Analysis & Forecast (2018-2028): A $103.57 Billion Opportunity, Growing at a CAGR of 11.02%

Dublin, Dec. 10, 2018 (GLOBE NEWSWIRE) -- The "Global Vaccine Market: Focus on Product ...

author_avatar
NASDAQ Market News